Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 905 shares at $152.53 ($69K) on 2013-11-15, disclosed to the SEC on 2013-11-19.
Seasonal sale ($69k) by Executive VP U.S. Generics — this insider has traded PRGO in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 450 | $0 | 0.0% |
| 2 | $152.53 | 455 | $69K | 100.0% |
| Total | $76.69 avg | 905 | $69K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-09-03 | $419K | — | Filing → |